- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alembic Pharmaceuticals received USFDA final approval for Ticagrelor Tablets, 60 mg, a generic equivalent to Brilinta. This drug has an estimated market size of US$ 236 million. This approval expands Alembic's US portfolio of 227 ANDA approvals.